¥190 Million from AstraZeneca for Diabetes Treatment Production Line in Taizhou

10 years on from its founding, the investment will turn the AstraZeneca facility in the China Medical City into a global production base; ¥10 billion in annual output is projected. Full story (in Chinese) via this link; read the absolute essentials about Taizhou via this link.